selegiline has been researched along with oxadiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agata, M; Matsumoto, J; Sasada, N; Takahashi, T; Toyofuku, H | 1 |
| Arakawa, R; Cselényi, Z; Elmore, CS; Farde, L; Halldin, C; Johnström, P; Kingston, L; Moein, MM; Nag, S; Stepanov, V; Varnäs, K | 1 |
2 other study(ies) available for selegiline and oxadiazoles
| Article | Year |
|---|---|
A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biogenic Monoamines; Brain; Dopamine; In Vitro Techniques; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Neostriatum; Nervous System Diseases; Oxadiazoles; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Selegiline | 1994 |
The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans.
Topics: Adult; Allosteric Regulation; Animals; Binding Sites; Brain; Carbon Radioisotopes; Female; Humans; Imidazoles; Macaca fascicularis; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Oximes; Positron-Emission Tomography; Psychoses, Substance-Induced; Pyridines; Radiopharmaceuticals; Receptor, Metabotropic Glutamate 5; Selegiline; Young Adult | 2020 |